a16z Podcast
Can we make science as fast as software?
In this episode, Erik Torenberg talks with Patrick Hsu (cofounder of Arc Institute) and a16z general partner Jorge Conde about Arc’s “virtual cells” moonshot, which uses foundation models to simulate biology and guide experiments.
They discuss why research is slow, what an AlphaFold-style moment for cell biology could look like, and how AI might improve drug discovery. The conversation also covers hype versus substance in AI for biology, clinical bottlenecks, capital intensity, and how breakthroughs like GLP-1s show the path from science to major business and health impact.
Resources:
Find Patrick on X: https://x.com/pdhsu
Find Jorge on X: https://x.com/JorgeCondeBio
Stay Updated:
Find a16z on X
Find a16z on LinkedIn
Listen to the a16z Podcast on Spotify
Listen to the a16z Podcast on Apple Podcasts
Follow our host: https://twitter.com/eriktorenberg
Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

-
Boss Talk with Ben Horowitz
Boss Talk is a weekly live show on Clubhouse, where a16z cofounder Ben Horowitz and Databricks CEO Ali Ghodsi discuss CEO stuff, leadership stuff, management stuff… you know, boss stuff. Here we share the second…
-
All About Ransomware
In just the last couple years, ransomware has grown into a multibillion dollar industry. It has evolved from taking systems and servers hostage to stealing data, and it has proven capable of shutting down global…
-
One on One with Marc and Ben
On social audio app Clubhouse, Marc Andreessen and Ben Horowitz are hosting a new live show called “One on One with A and Z”, where they go deep on questions submitted via Twitter. The show…
-
Amazon Narratives: Memos, Working Backwards from Release, More
When you hear stories about Amazon’s “invention machine” — which led to a company with not just one or two products but several successful diverse lines of business — we often hear about things like:…
-
Anatomy of the SolarWinds Hack: Who What Where When How
In this special “3x”-long episode of our (otherwise shortform) news analysis show 16 Minutes — past such 2-3X explainer episodes have covered section 230, Tiktok, GPT-3, the opioid crisis, more — we cover the SolarWinds…
-
Psychedelics: Striking a Balance Between Benefits and Side Effects
In recent years, there’s been a shift in how we think about psychedelics – from drugs of abuse and recreation, to powerful drugs for treating neuropsychiatric conditions such as depression, addiction, and PTSD. But…
-
Developers as Creatives
The rise of developers — as buyers, as influencers, as a creative class — is a direct result of “software eating the world”, and of key shifts in IT from on-prem to cloud & SaaS…
-
Section 230: Everything You Need to Know — Tweets, Free Speech, Beyond
All about section 230 of the Communications Decency Act — in what Wired senior writer (and host of the Get Wired podcast) described as “one of the clearest-but-still-nuanced explainers I’ve heard – worth listening to”. …
-
Baumol’s Cost Disease, in Healthcare… and Where We Go Next
If software’s eating the world — and more specifically, bringing costs down and increasing productivity through entire industries — why have some industries, like healthcare, been so resistant? And what could the future look like…
-
Words of 2020! (and Metaphors, and Interfaces of the Year)
“In a year that left us speechless, 2020 has been filled with new words unlike any other”… so it’s unprecedented that for the first time, the Oxford English Dictionary did NOT name a word of…